A3P Biomedical AB is a Swedish company with a global mission – to radically improve precision in prostate cancer diagnostics and treatment. The company’s leading product is Stockholm3, a clinically and commercially validated blood test for early detection of aggressive prostate cancer. The test is developed by researchers at Karolinska Institutet.

For more information please contact us.